ZIOP - (NASDAQ)
Price: $2.62 Change: + 0.60
|May 24, 2013 4:11 PM ET|
|Murray Brennan, M.D.||1|
|James A. Cannon|
Chief Financial Officer and Vice Chairman, BBDO
James (Jim) Cannon is Vice Chairman, Chief Financial Officer and a member of the Board of Directors of BBDO Worldwide. In this capacity, he oversees the financial management of BBDO operations in 77 countries. Jim joined BBDO in 1967, was promoted to Chief Financial Officer of the agency in 1984, and was elected to its Board of Directors one year later. An integral member of the team that formed Omnicom via a unique three-agency merger of BBDO, DDB and Needham Harper & Steers, Jim became Comptroller of the new group (NYSE: OMC) and a member of its Board of Directors in 1986, a position he held through 2002. In 1987, he was appointed Director of Financial Operations of the Omnicom Group, serving in this capacity until early 1989 when he rejoined BBDO Worldwide as Executive Vice President and Chief Financial Officer. His return was concurrent with that of Allen Rosenshine who became Chairman and Chief Executive Officer of BBDO after heading Omnicom. Jim was promoted to Vice Chairman of the agency in 1990. Jim is a graduate of Pace University and served in the US Marine Corps.
|Senator Wyche Fowler, Jr., J.D.|
|Randal J. Kirk|
|Jonathan Lewis, M.D., Ph.D.|
|Michael Weiser, M.D., Ph.D.||1|
Stock transaction information provided by EDGAR Online. ZIOPHARM Oncology, Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information. For recent transactions, including non-monetary transactions such as stock option grants, see our Section 16 SEC filings page.
1Member of Stock Plan subcommittee